These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 33253080

  • 21. Combination antibiotic susceptibility of biofilm-grown Burkholderia cepacia and Pseudomonas aeruginosa isolated from patients with pulmonary exacerbations of cystic fibrosis.
    Dales L, Ferris W, Vandemheen K, Aaron SD.
    Eur J Clin Microbiol Infect Dis; 2009 Oct; 28(10):1275-9. PubMed ID: 19575248
    [Abstract] [Full Text] [Related]

  • 22. Phenotypic and Genotypic Adaptations in Pseudomonas aeruginosa Biofilms following Long-Term Exposure to an Alginate Oligomer Therapy.
    Oakley JL, Weiser R, Powell LC, Forton J, Mahenthiralingam E, Rye PD, Hill KE, Thomas DW, Pritchard MF.
    mSphere; 2021 Jan 20; 6(1):. PubMed ID: 33472983
    [Abstract] [Full Text] [Related]

  • 23. Transcriptome Analysis of Pseudomonas aeruginosa Biofilm Infection in an Ex Vivo Pig Model of the Cystic Fibrosis Lung.
    Harrington NE, Littler JL, Harrison F.
    Appl Environ Microbiol; 2022 Feb 08; 88(3):e0178921. PubMed ID: 34878811
    [Abstract] [Full Text] [Related]

  • 24. Dispersal of Epithelium-Associated Pseudomonas aeruginosa Biofilms.
    Zemke AC, D'Amico EJ, Snell EC, Torres AM, Kasturiarachi N, Bomberger JM.
    mSphere; 2020 Jul 15; 5(4):. PubMed ID: 32669459
    [Abstract] [Full Text] [Related]

  • 25. Killing effect of nanoencapsulated colistin sulfate on Pseudomonas aeruginosa from cystic fibrosis patients.
    Sans-Serramitjana E, Fusté E, Martínez-Garriga B, Merlos A, Pastor M, Pedraz JL, Esquisabel A, Bachiller D, Vinuesa T, Viñas M.
    J Cyst Fibros; 2016 Sep 15; 15(5):611-8. PubMed ID: 26708265
    [Abstract] [Full Text] [Related]

  • 26. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
    Furiga A, Lajoie B, El Hage S, Baziard G, Roques C.
    Antimicrob Agents Chemother; 2015 Dec 28; 60(3):1676-86. PubMed ID: 26711774
    [Abstract] [Full Text] [Related]

  • 27. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V, Ratjen F.
    Cochrane Database Syst Rev; 2017 Oct 05; 10(10):CD009528. PubMed ID: 28981972
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V, Ratjen F.
    Cochrane Database Syst Rev; 2012 Nov 14; 11():CD009528. PubMed ID: 23152277
    [Abstract] [Full Text] [Related]

  • 32. Human airway mucus alters susceptibility of Pseudomonas aeruginosa biofilms to tobramycin, but not colistin.
    Müller L, Murgia X, Siebenbürger L, Börger C, Schwarzkopf K, Sewald K, Häussler S, Braun A, Lehr CM, Hittinger M, Wronski S.
    J Antimicrob Chemother; 2018 Oct 01; 73(10):2762-2769. PubMed ID: 29982453
    [Abstract] [Full Text] [Related]

  • 33. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
    Price KE, Naimie AA, Griffin EF, Bay C, O'Toole GA.
    J Bacteriol; 2016 Jan 15; 198(2):237-47. PubMed ID: 26483523
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Conceptual Model of Biofilm Antibiotic Tolerance That Integrates Phenomena of Diffusion, Metabolism, Gene Expression, and Physiology.
    Stewart PS, White B, Boegli L, Hamerly T, Williamson KS, Franklin MJ, Bothner B, James GA, Fisher S, Vital-Lopez FG, Wallqvist A.
    J Bacteriol; 2019 Nov 15; 201(22):. PubMed ID: 31501280
    [Abstract] [Full Text] [Related]

  • 39. Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
    Howlin RP, Cathie K, Hall-Stoodley L, Cornelius V, Duignan C, Allan RN, Fernandez BO, Barraud N, Bruce KD, Jefferies J, Kelso M, Kjelleberg S, Rice SA, Rogers GB, Pink S, Smith C, Sukhtankar PS, Salib R, Legg J, Carroll M, Daniels T, Feelisch M, Stoodley P, Clarke SC, Connett G, Faust SN, Webb JS.
    Mol Ther; 2017 Sep 06; 25(9):2104-2116. PubMed ID: 28750737
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.